Orsola Savi, | |
1135 Farmington Ave, Berlin, CT 06037-5200 | |
(860) 828-0772 | |
Not Available |
Full Name | Orsola Savi |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 1135 Farmington Ave, Berlin, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295274678 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | PCT.0009014 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Orsola Savi, 1135 Farmington Ave, Berlin, CT 06037-5200 Ph: (860) 828-0772 | Orsola Savi, 1135 Farmington Ave, Berlin, CT 06037-5200 Ph: (860) 828-0772 |
News Archive
Affymax, Inc. and Takeda Global Research & Development Center, Inc., U.S., today announced that the U.S. Food and Drug Administration (FDA) accepted for review the New Drug Application (NDA) for peginesatide (formerly known as Hematideā¢) for the treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis.
Queensland Health has introduced a new maternity scheme. The expecting mothers in Dysart, Middlemount, Moranbah, Clermont and Glenden shall now have a wider variety of options to choose from when it comes to choosing how their pregnancy be managed.
MorphoSys AG and Immatics Biotechnologies GmbH announced today a strategic alliance to generate novel antibody-based therapeutics against multiple proprietary cancer antigens recognized by T cells.
Finland has made its first specific commitment to the development of European biomedical research infrastructures (BMS ESFRIs) by supporting a joint pilot infrastructure project in bioinformatics (ELIXIR), biobanking (BBMRI) and translational research (EATRIS). The initial commitment of 1.85 M- is to support preparation and pilot studies in 2010.
Tumors need a healthy supply of blood to grow and spread. Researchers at the Stanford University School of Medicine have identified a molecule that regulates blood vessel growth that is often found at less-than-normal levels in human tumors. Blocking the expression of the molecule, called PHD2, allows human cancer cells to grow more quickly when implanted into mice and increases the number of blood vessels feeding the tumor.
› Verified 9 days ago
Cynthia Ellen Huge, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 77 Old Brickyard Ln, Berlin, CT 06037 Phone: 800-282-4321 Fax: 800-643-5093 | |
Victoria Gancarczyk, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1135 Farmington Ave, Berlin, CT 06037 Phone: 860-828-0772 | |
Donald J. Boisvert, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 77 Old Brickyard Ln, Suite 1, Berlin, CT 06037 Phone: 800-282-4321 Fax: 800-643-5093 | |
Babak Atighechi, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 207 Webster Square Road, Berlin, CT 06037 Phone: 860-828-7511 | |
Dr. Agata Dabek, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 308 Berlin Tpke, Berlin, CT 06037 Phone: 860-829-0800 | |
Andrea Lynn Johnson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 980 Farmington Ave, Berlin, CT 06037 Phone: 860-828-6844 Fax: 860-828-6738 | |
Mr. Sean Michael Rooney, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 77 Old Brickyard Ln, Berlin, CT 06037 Phone: 860-829-6575 |